CD8A and non-small cell lung carcinoma: Administration with docetaxel and rocaltrol increased the percentage of IFN-γ+CD4+, TNF-α+CD8+, and TNF-α+Vγ9Vδ2+ T cells and the level of TNF-α in serum compared with that of administration with a single dose of docetaxel (figure 2F–I and online supplemental figure S7B–D) in patients with NSCLC.